Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
ChatGPT ads land in U.K. as OpenAI outlines EU privacy rules
OpenAI has updated its EU ad policy to confirm personalized ads will only be served to users who explicitly opt in.
TikTok now has a seat next to Amazon and Walmart in RFPs
TikTok Shop has earned its place in the brief. What nobody has worked out yet, is who should actually run it.
Walmart executives see the promise of AI, but also the costs
Walmart is cracking down on redundant or inefficient uses of AI internally, knowing the technology has a price tag.